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Abstract: BACKGROUND AIMS Cultured patient-specific keratinocyte sheets have been used clini-
cally since the 1970s for the treatment of large severe burns. However, despite significant developments
in recent years, successful and sustainable treatment is still a challenge. Reliable, high-quality grafts
with faster availability and a flexible time window for transplantation are required to improve clinical
outcomes. METHODS Keratinocytes are usually grown in vitro at 37°C. Given the large temperature
differences in native skin tissue, the aim of the authors’ study was to investigate thermal conditioning
of keratinocyte sheet production. Therefore, the influence of 31°C, 33°C and 37°C on cell expansion and
differentiation in terms of proliferation and sheet formation efficacy was investigated. In addition, the
thermal effect on the biological status and thus the quality of the graft was assessed on the basis of
the release of wound healing-related biofactors in various stages of graft development. RESULTS The
authors demonstrated that temperature is a decisive factor in the production of human keratinocyte
sheets. By using specific temperature ranges, the authors have succeeded in optimizing the individual
manufacturing steps. During the cell expansion phase, cultivation at 37°C was most effective. After 6
days of culture at 37°C, three times and six times higher numbers of viable cells were obtained compared
with 33°C and 31°C. During the cell differentiation and sheet formation phase, however, the cells ben-
efited from a mildly hypothermic temperature of 33°C. Keratinocytes showed increased differentiation
potential and formed better epidermal structures, which led to faster biomechanical sheet stability at
day 18. In addition, a cultivation temperature of 33°C resulted in a longer lasting and higher secretion
of the investigated immunomodulatory, anti-inflammatory, angiogenic and pro-inflammatory biofactors.
CONCLUSIONS These results show that by using specific temperature ranges, it is possible to accelerate
the large-scale production of cultivated keratinocyte sheets while at the same time improving quality.
Cultivated keratinocyte sheets are available as early as 18 days post-biopsy and at any time for 7 days
thereafter, which increases the flexibility of the process for surgeons and patients alike. These findings
will help to provide better clinical outcomes, with an increased take rate in severe burn patients.
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A B S T R A C T
Background aims: Cultured patient-specific keratinocyte sheets have been used clinically since the 1970s for
the treatment of large severe burns. However, despite significant developments in recent years, successful
and sustainable treatment is still a challenge. Reliable, high-quality grafts with faster availability and a flexi-
ble time window for transplantation are required to improve clinical outcomes.
Methods: Keratinocytes are usually grown in vitro at 37°C. Given the large temperature differences in native
skin tissue, the aim of the authors’ study was to investigate thermal conditioning of keratinocyte sheet pro-
duction. Therefore, the influence of 31°C, 33°C and 37°C on cell expansion and differentiation in terms of pro-
liferation and sheet formation efficacy was investigated. In addition, the thermal effect on the biological
status and thus the quality of the graft was assessed on the basis of the release of wound healing-related bio-
factors in various stages of graft development.
Results: The authors demonstrated that temperature is a decisive factor in the production of human keratino-
cyte sheets. By using specific temperature ranges, the authors have succeeded in optimizing the individual
manufacturing steps. During the cell expansion phase, cultivation at 37°C was most effective. After 6 days of
culture at 37°C, three times and six times higher numbers of viable cells were obtained compared with 33°C
and 31°C. During the cell differentiation and sheet formation phase, however, the cells benefited from a
mildly hypothermic temperature of 33°C. Keratinocytes showed increased differentiation potential and
formed better epidermal structures, which led to faster biomechanical sheet stability at day 18. In addition, a
cultivation temperature of 33°C resulted in a longer lasting and higher secretion of the investigated immuno-
modulatory, anti-inflammatory, angiogenic and pro-inflammatory biofactors.
Conclusions: These results show that by using specific temperature ranges, it is possible to accelerate the
large-scale production of cultivated keratinocyte sheets while at the same time improving quality. Cultivated
keratinocyte sheets are available as early as 18 days post-biopsy and at any time for 7 days thereafter, which
increases the flexibility of the process for surgeons and patients alike. These findings will help to provide bet-
ter clinical outcomes, with an increased take rate in severe burn patients.
© 2021 International Society for Cell & Gene Therapy. Published by Elsevier Inc. This is an open access article








Skin provides an invaluable protective barrier for the human
body. If the skin or other tissues are injured by heat, cold, electricity,
chemicals, friction or radiation, it is referred to as a burn. Burns are a
serious public health problem worldwide. According to the World
Health Organization, around 180 000 people die of burns every year
[1]. After a severe burn of over 40% of the total body surface,
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patients suffer from dramatic loss of their epidermal and dermal
layers, and the natural repair mechanisms are also significantly
damaged. These serious injuries lead to a state of immunosuppres-
sion, which predisposes burn patients to infectious complications.
Patients are at high risk of infection from inhalation injuries and for
the development of sepsis secondary to pneumonia, catheter-
related infections or suppurative thrombophlebitis [2]. In these
patients, the remaining unaffected skin areas are often not sufficient
to provide autograft coverage.
To treat this extensive skin damage, large-scale in vitro cultivated
skin grafts can be made from the patient’s own cells (autologous). Kera-
tinocytes, the main cell type present in the epidermis, are isolated from
an autologous skin biopsy and cultivated in vitro to form a multi-layer
cell sheet (Figure 1). These keratinocyte sheets can be transferred to car-
riers (e.g., Vaseline gauzes) to facilitate subsequent implantation [3]. The
original technique was developed by Rheinwald and Green [4] and
Green et al. [5] in the 1970s. However, despite considerable progress in
the large-scale production of keratinocyte sheets in recent years, their
successful grafting remains challenging. In fact, graft take rates show
enormous variability, especially in deep and infected burn wounds,
which necessitates further improvements [6]. For example, a highly
inflammatory situation in combination with low neovascularization can
be problematic for successful grafting. The use of cultivated skin grafts
represents a possibility for the treatment of extensive burn lesions since
they allow the resurfacing of a significant area of burn that cannot be
achieved with other surgical techniques based on autologous grafts [7].
Compared with allografts, xenografts, dermal substitutes and biosyn-
thetic dressings, however, the production of cultured skin grafts takes a
long time, up to 34 weeks [8,9]. During this period, the patient’s state
of health cannot be predicted. To be able to react more flexibly to
unforeseen clinical incidents in the patient, an extended and mainly
shorter time frame for transplantation would be helpful. For this reason,
the authors attempted modifications to the large-scale keratinocyte
sheet manufacturing protocol to create an extended flexible transplan-
tationwindow that allows the surgeon to adjust the time of transplanta-
tion according to the patient’s state of health.
Fig. 1. (A) Schematic representation of autologous keratinocyte sheet production. After skin biopsy, the epidermal cells are isolated and expanded. After reaching the required number of cells,
sheet formation is initiated. Thereafter, the keratinocyte sheet can be harvested and transplanted. For production optimization, the effect of temperature and time on the different production
steps of cell isolation, cell expansion and sheet formation during keratinocyte sheet production was investigated. (B) To find a possible time window for flexible transplantation, the keratino-
cyte sheets were examined with regard to their positive (blue) and negative (red) modulators between day 17-25 of total culture. (Color version of figure is available online).
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The native skin and its constituent cells, such as keratinocytes, are
exposed to large temperature differences. The cells have to go through a
temperature gradient from 37°C in the innermost basal layer to 32°C on
the skin surface [10]. Since temperature appears to be involved in sev-
eral pathways that regulate the balance between proliferation and dif-
ferentiation of human keratinocytes, optimized temperature conditions
could be used in a targeted manner to accelerate the process of kerati-
nocyte sheet production and outcome optimization.
The effect of hypothermic culture on large-scale keratinocyte sheet
manufacturing and engraftment properties has not yet been described.
The authors hypothesized that temperature—specifically hypothermic
conditions—may alter and perhaps even enhance the production of
wound healing-related biofactors. This would improve overall keratino-
cyte sheet adhesion to the wound bed and, by extension, provide better
clinical results, with an enhanced graft take rate in patients.
To give future burn patients the best possible treatment, the aim of
the authors’ study was to (i) expand the implantability window and
speed up production (time) and (ii) characterize and maximize the
activity of implanted keratinocyte sheets (quality). The influence of tem-
perature on the individual in vitro phases of keratinocyte sheet
manufacturing, such as biopsy storage, cell isolation, cell expansion and
sheet formation, was investigated (Figure 1). The main focus was on the
reliability and quality of the keratinocyte sheets. In addition to bio-
mechanical stability (sheet thickness), the latter also includes the biolog-
ical status of the sheets, such as cell differentiation status, biological
properties and activity. With regard to a transplantation, the biological
properties of cultivated skin grafts have to be ideal for the harsh envi-
ronment of a debrided burn to successfully reconstitute the skin tissue.
Dynamic levels of growth factors, anti- and pro-inflammatory cytokines
and other important wound healing modulators secreted by keratino-
cyte sheets were evaluated at various stages of their in vitro develop-
ment to determine the quality of the sheet cultures.
Methods
Source of human keratinocytes
For the present study, human keratinocytes were isolated from
split- or full-thickness skin samples collected from female patients
undergoing plastic surgery at the Division of Plastic Surgery and
Hand Surgery of the University Hospital Z€urich, Switzerland. The
informed consent was obtained for experimentation with human
material and the privacy rights of the patients participating in the
study were always be observed (institutional ethics committee
license KEK-ZH-2014-0197). The skin tissue samples were retrieved
from remnant operative tissue, which would otherwise have been
discarded, excised from the breast or abdominal region. Patient age
range and sample number are specified for each assay in the follow-
ing sections.
Isolation of human keratinocytes
The skin biopsies were placed in a Petri dish and the surface area
determined with a ruler. The isolation of keratinocytes from full- or
split-thickness samples was performed using the same procedure.
Briefly, the skin tissue was micro-dissected in small pieces of approx-
imately 10 £ 10 mm and digested with Dispase solution (Corning,
New York, USA) 12 U/mL in phosphate-buffered saline (PBS) for
1518 h at 4°C. A maximum biopsy size of 8 cm2was digested in
15 mL Dispase to maintain enzyme efficiency. Thereafter, the epider-
mis and dermis were mechanically separated. For isolation of the epi-
dermal cell fraction, the epidermal layer was further digested with
trypsin/ethylenediaminetetraacetic acid 5x (Thermo Fisher Scientific,
Waltham, MA, USA) for 1520 min at 37°C. The digestion was halted
by adding 3.75 mg/mL soybean trypsin inhibitor (Thermo Fisher
Scientific). The cell isolation efficiency was evaluated in 59 biopsy
samples (patient age range, 42.2 § 12.4 years).
To that end, a sample of the isolated cells from each biopsy was
collected and stained with Acridine Orange and 40,6-diamidino-2-
phenylindole to determine the number of isolated cells as well as
their viability (NucleoCounter NC-200; ChemoMetec, Lillerød, Den-
mark). The isolation efficiency was reported per biopsy sample as iso-
lated viable cells/cm2biopsy. In addition, the authors examined
whether the age of the donors had a significant impact on the isola-
tion efficiency. The mean § standard deviation (SD) of the isolation
efficiency was calculated. Furthermore, the Pearson correlation was
evaluated between isolated viable cells and biopsy surface area as
well as between isolated viable cells/cm2 biopsy and donor age. An
independent two-sided t-test was performed to compare the number
of viable cells/cm2 biopsy isolated after a 6-h versus 24-h storage
period. P < 0.05 indicated statistical significance.
Biopsy storability
To test the effect of cold temperature storage on biopsy viability,
four biopsies (patient age range, 44.5 § 1.6 years) were divided into
five equal pieces each and placed in a closed and sterile container at
4°C in maintenance medium CnT-XP3 (CELLnTEC Advanced Cell Sys-
tems AG, Bern, Switzerland) in a refrigerator. One piece of each
biopsy was taken out of storage after 0, 6, 12, 18 and 24 h. Cells were
isolated and assessed for the number of isolated viable cells using the
NucleoCounter. The number of isolated viable cells/cm2 biopsy from
all four biopsy samples was reported for each time point.
Human keratinocyte proliferation
To analyze the effect of thermal conditioning on cell proliferation
kinetics, keratinocytes from three patient biopsies (patient age range,
47.3 § 24.5 years) were seeded at 10000 cells/cm2 in 24-well plates
coated with bovine collagen I 6 mg/cm2 (Symatese, Chaponost,
France). Cells were cultivated at 37°C, 33°C and 31°C in triplicate
using the chemically defined and xenogeneic-free expansion medium
CnT-Prime (CELLnTEC Advanced Cell Systems AG) at 37 °C in a
humidified atmosphere and 5% carbon dioxide (CO2). To minimize
the risk of contamination, the medium was supplemented with
100 U/mL penicillin (Sigma-Aldrich, St Louis, MO, USA) and 100 mg/
mL streptomycin (Sigma-Aldrich) for the first 3 days of culture. Every
23 days, the culture medium was changed with unsupplemented
CnT-Prime medium until cells reached 7090% confluency.
A colorimetric proliferation assay with Crystal Violet (Sigma-
Aldrich) was performed to determine the number of viable cells in
the monolayer cultures during the expansion phase after 0, 24, 72
and 144 h. A standard curve was established by seeding keratinocytes
at 100 000, 50 000, 25000, 12 500, 6250 and 0 cells/well in a 24-well
plate and measuring the Crystal Violet assay signal at day 0. At the
individual time points, the cells were fixed with methanol and
stained with 0.1% Crystal Violet for 5 min. The cell layer was dried
and decolorized with a sodium dodecyl sulfate solution (0.5% with
ethanol 50% in 0.5 M tris[hydroxymethyl]aminomethane hydrochlo-
ride, pH 7.8) for 60 min at 37°C. The optical density of the superna-
tant was read at the absorption maximum of 590 nm. Using the
internal standard, the mean § SD of viable cells/cm2 across all three
biopsies was calculated for each time point. A one-way analysis of
variance with a Bonferroni post-hoc test was performed for each
time point, comparing the three temperatures. P < 0.05 was chosen
as the statistically significant threshold.
Keratinocyte sheet formation
To analyze the influence of temperature on the production and qual-
ity of keratinocyte sheets, differentiation of keratinocytes and sheet
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formation at different temperatures were analyzed. Freshly isolated ker-
atinocytes of six patient biopsies (patient age range, 46.0 § 8.1 years)
were seeded at a density of 30000 viable cells/cm2 on flasks coated
with bovine collagen I and expanded at 37°C in a humidified atmo-
sphere and 5% CO2. After reaching confluency, production of keratino-
cyte sheets was initiated by passaging the cells and plating them at a
density of 5000 viable cells/cm2 in CnT-Prime on T115 peel-off flasks
(Techno Plastic Products AG, Trasadingen, Switzerland) coated with
bovine collagen I. When the cells reached 8090% confluency after
35 days, keratinocyte differentiation was induced using the chemically
defined and xenogeneic-free differentiation medium CnT-Prime 2D
(CELLnTEC Advanced Cell Systems AG) supplemented with 1.2 mM cal-
cium chloride (Sigma-Aldrich). Henceforth, the culture flasks were culti-
vated at 31°C, 33°C and 37°C and 5% CO2 for the remaining days of
differentiation culture. A medium change with CnT-Prime 2D and cal-
cium chloride was performed every 2 days in all conditions. For proteo-
mic analysis, medium supernatants from all culture conditions were
collected in duplicate before each medium change from day 17 until
day 25 of total culture time. Supernatant samples were stored at 80°C
until analysis.
Sheet formation assay
From day 17 until day 25 of total culture, the keratinocyte sheets
were harvested every second day by enzymatically treating with
0.25% (w/v) Dispase II (Thermo Fisher Scientific) at 37°C for 10 min.
After flushing the sheets with PBS, the skin grafts were carefully
detached from the cell culture flasks and lifted with two tweezers to
see whether the biomechanical stability of the sheets was given at
the individual days of culture. For further analysis, representative
keratinocyte sheet samples with an inner diameter of 6 mm were
taken using biopsy punches.
Histology and immunohistochemistry characterization of keratinocyte sheets
For qualitative evaluation of tissue organization, keratinocyte sheet
samples were fixed with 4% formalin for 1 h at room temperature,
transferred in a 2% agarose plug (Carl Roth GmbH, Karlsruhe, Germany)
and carefully spread using two tweezers. Stepwise dehydration through
a series of graded alcohols was performed, followed by embedding in
paraffin (Paraplast; Biosystems Switzerland AG, Muttenz, Switzerland)
and slicing into 5-mm sections. To assess the tissue composition and
architecture of the keratinocyte sheets, hematoxylin and eosin staining
was performed. All sections were analyzed by a single operator using an
inverted light microscope (Axiovert 40 CFL and Axioplan II; Carl Zeiss
AG, Oberkochen, Germany).
In addition, expression profiles of the keratinocyte sheets with
regard to early- and late-stage differentiation markers were analyzed
using the primary antibodies anti-desmoglein 3 and anti-filaggrin,
respectively. Specifically, sections were transferred to target retrieval
solution, high pH (K8004; Dako Denmark A/S, Glostrup, Denmark), in
a PT Link (PT100/PT101; Dako Denmark A/S) for 20 min at 97°C, per-
forming a three-in-one procedure (i.e., deparaffinization, rehydration
and heat-induced epitope retrieval) on the formalin-fixed, paraffin-
embedded tissue sections. A standard immunohistochemistry stain-
ing protocol was performed on an Autostainer Link 48 instrument
(Dako Denmark A/S) for desmoglein 3 (clone 3G133, mouse IgG1,
ab14416; Abcam, Cambridge, UK) and filaggrin (mouse IgG, ab17808;
Abcam) at a working dilution of 1:100 in antibody diluent (S2022;
Dako Denmark A/S) for 20 min at room temperature. The visualiza-
tion system consisted of the K4001 and K4008 EnVision horseradish
peroxidase/3,30-diaminobenzidine (DAB) system (Dako Denmark A/
S), with hematoxylin as counterstain. Tissue formation, including
thickness of the keratinocyte sheets and expression intensity of des-
moglein 3 and filaggrin, was evaluated using ImageJ 1.52a software
(National Institutes of Health, Bethesda, MD, USA). To measure sheet
thickness, three measurements were carried out on each histology
slide. The expression intensity of desmoglein 3 and filaggrin, indi-
cated by intensity of the DAB stain, was quantified using the DAB
color deconvolution algorithm of ImageJ [11]. The mean § SD sheet
thickness as well as DAB intensity of all samples was given for each
time point.
Proteomics
To analyze themetabolic state and intercellular signaling of the kera-
tinocytes within the sheets, targeted microarray using multiplex tech-
nology (Luminex; R&D Systems, Minneapolis, MN, USA) was used. With
this novel technique, complete profiles of cells and cell cultures can be
identified [12]. Magnetic beads coated with the specific antibodies were
mixed with the sample (supernatant) and incubated. Thereafter, the
bonded analytes were detected using the biotinylated streptavidin com-
plex. Using the Bio-Plex Pro human cytokine 27-plex assay (Bio-Rad,
Hercules, CA, USA), 27 parameters, including growth factors/proteins,
regulating cell growth and division as well as angiogenesis, were ana-
lyzed for each sample. The focus during analysis was on pro- and anti-
inflammatory cytokines as well as markers regulating proliferation, dif-
ferentiation and survival of cells within the keratinocyte sheet. Thus, the
following eight analytes were chosen for analysis: interferon gamma
(IFN-g), IL-10, IL-4, IL-1b, IL-8, tumor necrosis factor alpha (TNF-a),
platelet-derived growth factor type BB (PDGF-BB) and vascular endo-
thelial growth factor (VEGF). Data were acquired using a BioPlex 200
reader (Bio-Rad). The mean concentration (pg/mL) § SD of the different
secretomes was calculated for each time point and presented over time.
For statistical significance, a one-way analysis of variance with a Bonfer-
roni post-hoc test was performed. P= 0.05 indicated the statistically sig-
nificant threshold.
Storability of keratinocyte sheets
To assess the time-dependent usability of the keratinocyte sheets,
the storability of the sheets was investigated. Therefore, sheets made
of cells from four different patient biopsies (patient age range, 43.7 §
25.2 years) were cultivated and enzymatically detached as described
before. These were then stored either at 4°C in a refrigerator or at 37°
C in an incubator (5% CO2) in CnT-Prime 2D or CnT-XP3 medium. In
addition to temperature, two storage conditions were compared: one
with the transport dressing Jelonet (Smith & Nephew, Mississauga,
Canada) and one without any dressing (n = 4). The viability of the ker-
atinocyte sheets was assessed immediately after harvest (0 h) as well
as after 3, 6, 12, 24, 48 and 72 h by a fluorescence-based live-dead
assay using fluorescein diacetate (Sigma-Aldrich) and propidium
iodide (Sigma-Aldrich). Use of the fluorescent dyes fluorescein diace-
tate and propidium iodide allowed a simultaneous two-color deter-
mination of living cells and the dead cell population, respectively.
Keratinocyte sheets of each condition were incubated with 5 mg/mL
fluorescein diacetate in acetone and 1 mg/mL propidium iodide in
PBS for 5 min. After intensive washing with PBS, the samples were
analyzed using an inverted fluorescence microscope as mentioned
earlier. The viability of the keratinocyte sheet, indicated by the fluo-
rescence intensity of the fluorescein diacetate stain, was quantified
using ImageJ (mean gray value algorithm) and represented as a per-
centage (mean § SD) in correlation with the sample without storage
of the respective medium and temperature over time.
Statistical analysis
Statistical analysis was performed using SPSS Statistics 25.0.0.1 (IBM,
Armonk, NY, USA). Quantitative data are presented as mean § SD. The
individually chosen statistical comparison was specified earlier for each
assay. P< 0.05 was considered statistically significant.
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Results
Cell isolation efficiency
The cell isolation procedure was reliable. Human keratinocytes were
successfully isolated from all 59 biopsies, with biopsy surface sizes
between 1.6 and 18 cm2. The mean number of isolated viable cells was
4.29 § 2.12 million cells/cm2 biopsy (Figure 2A). A linear positive corre-
lation between isolated viable cells and biopsy surface area was found
(r = +0.803, P = 0.000) (Figure 2A). A weak negative correlation was
found between isolated viable cells/cm2 biopsy and donor age
(r = 0.275, P = 0.040) (Figure 2B). However, a relation between isola-
tion efficiency per cm2 biopsy and storage prior to enzymatic isolation
was demonstrated (Figure 2C). When comparing cell isolation after 6 h
and 24 h of storage, it was shown that the efficiency after 24 h of storage
at 4°C was significantly better. The number of viable cells/cm2 isolated
after 6 h of storage was 3.9 § 1.8 million cells/cm2, and this increased
after 24 h of storage, reaching 5.2 § 2.1 million cells/cm2 (P= 0.017). The
number of viable cells/cm2 isolated from split-thickness (4.1 §
2.8£ 106 cells) versus full-thickness biopsies (4.7 § 2.0£ 106 cells) was
not significantly different.
Biopsy stability
To investigate variability within the samples, biopsies were
divided into five equal parts and stored at 4°C in CnT-XP3 mainte-
nance medium until cell isolation. After 0, 6, 12, 18 and 24 h, cells
were isolated as previously described.
As can be seen in Figure 3, the number of isolated viable cells/cm2
biopsy was not significantly adversely affected during the first 12 h
of storage. However, after 12 h, some patients showed higher isola-
tion efficiency (see biopsy one), whereas others showed an opposite
trend (see biopsy three).
Thermal conditioning cell expansion
After successful cell isolation, the effect of hypothermic condition-
ing on the proliferation of human keratinocytes was examined at cul-
tivation temperatures of 31°C, 33°C and 37°C. Thermal conditioning
had a significant influence on the expansion behavior of human kera-
tinocytes (Figure 4). Lower temperature conditions of 31°C and 33°C
impaired cell expansion compared with 37°C. Population doubling
after 144 h at 37°C reached 3.25 § 0.29 doublings, or 1.7 times that
seen at 33°C, with 1.88 § 0.23 doublings, and five times that seen at
31°C, with 0.64 § 0.25 doublings. After 144 h, the number of viable
cells was highest when cultivated at 37°C (9 § 2.7 £ 104 cells/cm2).
This was three times (P= 0.011) and six times (P= 0.004) higher than
that seen in cultures cultivated at 33°C (3 § 0.4 £ 104 cells/cm2) and
31°C (1.5 § 0.3 £ 104 cells/cm2), respectively.
Keratinocyte sheet formation
The keratinocyte sheets cultivated at all three temperature condi-
tions showed successful sheet formation (Figure 5A). However, ther-
mal conditioning demonstrated a significant influence on the
formation of a multi-layer structure. At 17 days of culture, the kerati-
nocyte sheets of the individual patients featured biomechanical sta-
bility (i.e., were liftable) when cultivated at 33°C or 37°C. However,
the sheets cultivated at 31°C obtained a biomechanical stability at a
later time point and were not liftable before day 19. All liftable sheets
showed a homogeneous cell multi-layer, and no macroscopic differ-
ence between harvesting at day 17 or day 25 was observed. The tis-
sue structure was more compact with cultivation at 37°C compared
with that seen at lower temperatures. The thickness of the keratino-
cyte sheets showed a higher homogeneity during the day 17 to day
Fig. 2. Cell isolation efficiency. (A,B) Isolating human keratinocytes from 59 skin biopsies, a possible correlation between biopsy size and isolated viable cells as well as between
isolated viable cells/cm2 biopsy and donor age was investigated. (C) The impact of storage before enzymatic isolation was also analyzed. P < 0.05 was considered statistically
significant.
Fig. 3. Biopsy storability. Four human skin biopsies were stored at 4°C in CnT-XP3
medium. Over a period of 24 h, cells were isolated every 6 h and the number of isolated
viable cells/cm2 biopsy assessed.
Fig. 4. Impact of thermal conditioning on keratinocyte proliferation. Cell expansion
was investigated after 0, 24, 72 and 144 h at low and subphysiological temperature of
31°C (blue), intermediate temperature of 33°C (green) and high temperature of 37°C
(red). (Color version of figure is available online).
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25 window when cultivated at 37°C (13.3 § 5.0 mm) (Figure 5B). By
contrast, sheets cultivated at 33°C were 18.9 § 7.5 mm in thickness,
and those cultivated at 31°C were even thinner, at 17.1 § 9.1 mm.
Nevertheless, no statistically significant difference in thickness was
detected between the three groups (31°C, 33°C and 37°C).
The early differentiation status of keratinocytes, as indicated by
the expression profile of desmoglein 3, did not vary regardless of cul-
ture temperature or time (Figure 6A). From the 17th day (earliest
time of observation), keratinocytes showed constant expression over
time. By contrast, the late-stage differentiation marker filaggrin was
increasingly expressed from day 19 onward when cultivated at 37°C
and 33°C (Figure 6B). A notably delayed and heterogeneous expres-
sion of filaggrin was found at low temperature (31°C).
Keratinocyte sheet proteomics
The eight analyzed wound healing-related biofactors (IFN-g , VEGF,
PDGF-bb, TNF-a, IL-1b, IL-8, IL-4, IL-10) were detectable in the superna-
tant of the keratinocyte sheet cultures at all time points and temperatures
tested. Thermal conditioning as well as duration of culture affected the
levels of biofactors in both the detected peak and kinetics (Figure 7).
Within the sheet harvest window of 1725 days, those cultured at 37°C
exhibited an earlier increase in biofactor release, a narrower peak and a
trend toward an earlier decrease in secretion within the time window
compared with other temperatures. Sheets cultured at 31°C systemati-
cally exhibited lower levels of biofactors and slower release kinetics.
With regard to sheets cultured at 33°C, biofactor levels were the highest,
and the most sustainable release kinetics occurred in this time window.
Specifically, IFN-g release kinetics exhibited a 2-day delay, with levels at
37°C peaking on day 21 (190 § 26 pg/mL) and levels at 33°C rising to
approximately the same level (197 § 33 pg/mL) and plateauing at day
23. Levels at 31°C eventually rose starting at day 23. The peak (detected
at 37°C and 33°C, extrapolated at 31°C) did not seem to be affected by
thermal conditioning, only the kinetics of release. The same profile was
observed for TNF-a and IL-4, with levels at 37°C peaking on day 21 (TNF-
a, 30§ 4 pg/mL, IL-4, 2§ 0.5 pg/mL) and levels at 33°C rising to approxi-
mately the same level (TNF-a, 27 § 3 pg/mL, IL-4, 1.8 § 0.4 pg/mL) but
continuing to increase. VEGF also showed a temperature-related delay in
Fig. 5. Time- and temperature-dependent keratinocyte sheet formation. Keratinocyte sheets cultivated at 31°C, 33°C and 37°C were harvested every second day from day 17 to day
25. (A) Paraffin-embedded and sectioned keratinocyte sheets were analyzed for tissue architecture and sheet formation using hematoxylin and eosin histology staining. (B) Thick-
ness of the keratinocyte sheets was evaluated using ImageJ software (mean § SD, n = 6). Scale bar for all panels = 20mm. (Color version of figure is available online).
Fig. 6. Influence of time and temperature on keratinocyte sheet formation. From day 17 to day 25, keratinocyte sheets were immunohistochemically analyzed for graft maturation.
(A) Anti-desmoglein 3 indicates the early differentiation phase and (B) anti-filaggrin shows the late-stage differentiation phase of the keratinocytes within the sheets. For quantifica-
tion of the two stains, ImageJ software was used (mean § SD, n = 6). Scale bar for all panels = 20mm. (Color version of figure is available online).
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release, first peaking at 37°C, followed by 33°C and then 31°C. However,
the peak levels of VEGF were lowest at 31°C (6479 § 2337 pg/mL), fol-
lowed by 37°C (12599 § 1570 pg/mL), and highest at 33°C (15730 §
3295 pg/mL), which peaked at day 21 and maintained the highest levels
afterward compared with other temperatures. IL-10 showed a similar
profile, with less notable temperature-related differences. With regard to
PDGF and IL-8, the levels at all temperatures rose progressively over
time, with levels at 31°C remaining systematically lower. A progressive
increase in IL-1b levels over time was also observed, but the difference
between temperatures was less notable.
Keratinocyte sheet storability
Overall, keratinocyte sheets harvested at day 21 exhibited a pro-
gressive loss in viability when stored at 4°C or 37°C in CnT-2D
(growth) or CnT-XP3 (maintenance) medium (Figure 8A,B), maintain-
ing a viability above 50% of the 0 h signal (mean gray value, 22 § 4)
for varying amounts of time (Figure 8CF). A rapid loss in viability
with a similar shelf half-life (mean gray value, 22 § 9) was seen in all
conditions within the first 12 h of storage regardless of medium or
temperature (Figure 8C,E). After 24 h of storage, the viability of the
keratinocyte sheets fell below the threshold of 50% of the initial via-
bility signal (0 h) in all conditions. However, after this time point, the
loss of cell viability within the keratinocyte sheets slowed down, as
indicated by the flattening of the curves (Figure 8CF). Overall,
storage at a colder temperature was beneficial regardless of medium
or presence of carrier gauze, but this difference was mostly notable
from 24 h of storage onward.
In the presence of the transfer gauze Jelonet, cell viability further
decreased compared with the control sheet without carrier. A smaller
drop in viability due to the carrier was observed when using CnT-2D
medium, especially at 4°C. A notable decrease in viability was
observed after 48 h of storage in CnT-XP3 medium. Storage on Jelonet
at 4°C reduced viability by 25% compared with storage in CnT-XP3
medium only (P= 0.015). The same was observed at 37°C, with a 22%
decrease compared with the control without gauze carrier (P= 0.037).
Starting at 6 h, Jelonet reduced viability by 12%. Nevertheless, sheets
stored in CnT-2D medium at 4°C on Jelonet maintained viability at 34
§ 20% (mean gray value, 14 § 8) for longer storage, up to 72 h
(Figure 8C). In the absence of the transfer gauze, a stabilization of via-
bility was detected (Figure 8D,F), with the use of CnT-XP3 medium
showing an obvious beneficial effect compared with CnT-2Dmedium,
maintaining the 50% level up to 48 h.
Discussion
In this study, the authors demonstrated that temperature has a
clear influence on in vitro keratinocyte sheet production. Thermal
conditioning could be tailored to benefit each manufacturing step.
Biopsy cold storage and keratinocyte sheet cold storage were
Fig. 7. Secretome release of eight analyzed biofactors—the immunomodulatory factor (A) IFN-g; the angiogenic factors (B) VEGF and (C) PDGF-bb; the pro-inflammatory factors (D)
IL-1b, (E) IL-8 and (F) TNF-a; and the anti-inflammatory factors (G) IL-4 and (H) IL-10—at the three different temperatures, 31°C (blue), 33°C (green) and 37°C (red). Data are shown
as mean § SD, n = 6. Results from the ANOVA post-hoc Bonferroni statistical analysis comparing biofactor levels for each time point are shown in tables under each graph. P < 0.05
was considered statistically significant. ANOVA, analysis of variance; n.s., not significant (P  0.05). (Color version of figure is available online).
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Fig. 8. Stability of cultivated keratinocyte sheets. Sheets were harvested and subsequently stored either in Cnt-2D or CnT-XP3 medium at 4°C (A) respectively at 37°C (B) on the
wound dressing Jelonet and without wound dressing. After 0, 3, 6, 12, 24, 48 and 72 h, viability was assessed using the live-dead stain fluorescein diacetate/ propidium iodide. To
quantify the fluorescent signal of the fluorescein diacetate stain, ImageJ software was used. (CF) The course of viability over time is represented as the mean gray value of the
respective temperature and medium conditions. Mean § SD, n = 4. (Color version of figure is available online).
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beneficial overall. Human keratinocytes showed their maximum pro-
liferation rate at 37°C compared with lower temperatures. During dif-
ferentiation and sheet formation, keratinocytes benefited from
cultivation at 33°C, particularly with regard to improved epidermal
structure, biomechanical stability and biological activity (secretome
release). Finally, tailored thermal conditioning of the various sheet
production steps allowed large-scale sheet production to be ready for
implantation by day 18 following biopsy harvest and also allowed for
a wider implantability window, from day 18 to day 25, which could
then be tailored to the patient’s needs.
Production time and hypothermic conditioning of keratinocyte sheets
Initially, the technique of growing keratinocytes in confluent
sheets, with the expansion coefficient needed for large-scale produc-
tion (i.e., 600 times the surface expansion from biopsy to sheet area),
required 5 weeks [13]. Because of intensive process optimization in
the last decades, this manufacturing period was subsequently
reduced to 3 weeks [14]. Nevertheless, the characterization and har-
nessing of a transplantation efficiency window would enable sur-
geons to make an informed decision regarding the timing of a
grafting procedure by allowing them to choose the time frame when
the patient is most stable and graft maturation is ideal. Determining
the duration of the efficiency window would also allow surgeons to
work around delays caused by the sudden onset of complications in a
patient. This would undoubtedly translate into better clinical out-
comes in burn patients in the future.
In this study, the maximal window of transplant efficiency was
examined. The aim was to find the earliest time point when kera-
tinocyte sheets can be transplanted despite patient-to-patient var-
iability. To achieve the greatest possible clinical flexibility with
regard to transplantation, the extension of the window for a possi-
ble transplantation was also examined. The current literature
describes degenerative features of cultivated skin transplants in
cases of prolonged cultivation (up to 28 days) [8]. After a mature
phase of 1421 days, a senile phase is observable. Therefore, kera-
tinocyte sheet quality was analyzed in the current study between
day 17 and day 25 of total production time. With the help of opti-
mized temperature conditions, the individual manufacturing steps
should be accelerated and the safety and quality of the sheets
optimized.
For this purpose, keratinocytes were isolated from 4 cm2 human
skin biopsies, expanded and cultivated to form multi-layer keratino-
cyte sheets. Skin tissues were obtained by full- or split-thickness col-
lection from female patients aged 48.5 § 10.5 years. On average,
3.2 £ 106 § 1.35 £ 106 viable epidermal cells/cm2 tissue were iso-
lated. In accordance with the current literature [15], no differences in
cultured keratinocyte doublings were found among cells isolated
from the skin of different body areas (breast, abdomen) or from
donors of different ages.
To keep the cellular stress level as low as possible when isolating
primary cells and thus increase the number of isolated viable cells,
the authors examined storage of the skin biopsies in the maintenance
medium CnT-XP3. CnT-XP3 regulates tissue homeostasis, thereby
reducing cellular stress after biopsy. This observation was confirmed
in the present study, showing that storage in CnT-XP3 for 24 h signifi-
cantly increased the number of viable isolated cells (Figure 2C) com-
pared with isolation without storage. However, a closer look revealed
that there were enormous differences in isolation efficiency between
individual patients after 12 h of storage. Although in some cases one
can benefit from a 4-fold increase in cell isolation efficiency after
overnight storage, this is not the case systematically; in fact, the
opposite may happen (Figure 3). This patient-to-patient variability,
inherent to autologous therapies, means that to reduce overall time
until transplantation, the sheet preparation process should be started
as soon as possible.
To accelerate keratinocyte proliferation as well as keratinocyte
sheet formation, cells were cultivated at temperatures of 37°C and
33°C, which keratinocytes also experience in their native in vivo
development [10], as well as at subphysiological temperature condi-
tions of 31°C. The comparison confirmed that cultivation temperature
in vitro has a significant influence on the proliferation of the cells.
During the in vitro proliferation phase, the keratinocytes benefited
from an internal body temperature of 37°C. The two lower tempera-
ture conditions showed an adverse effect, with a significantly lower
proliferation rate. In other mammalian cell cultures, it has already
been demonstrated that a cultivation temperature of 31°C places cells
into cold shock and arrests cells in the G1 phase of the cell cycle,
which leads to reduced expansion of the cells, decreased biomass
and less cells [16]. Since the aim of this study was to accelerate cell
proliferation, a keratinocyte expansion temperature of 37°C would
be recommended based on these results.
The influence of the three temperatures was also examined with
regard to keratinocyte sheet formation between day 17 and day 25 of
harvest to assess biomechanical stability, sheet thickness and expres-
sion profile of the differentiation markers. Temperature had a pro-
found impact on the differentiation phase of keratinocytes. At 31°C,
sheet formation was significantly delayed (day 19), which was
reflected in the mechanical stability as well as the expression of the
late-stage differentiation marker filaggrin. Overall, the composition
of the sheets after cultivation at 31°C was more heterogeneous,
which was confirmed by the thickness measurement of the sheets,
and biomechanical stability was not reached before day 19 of culture.
The subphysiological temperature of 31°C had an obviously negative
influence on keratinocyte metabolism with regard to the differentia-
tion capacity of the cells. Keratinocyte sheets cultivated at a mildly
hypothermic temperature of 33°C generated better epidermal struc-
tures and an increased differentiation potential, which might be asso-
ciated with increased mitochondrial adenosine triphosphate
synthesis [1719]. Therefore, from a macroscopic and differentiation
point of view, forming human keratinocyte sheets at 37°C, and even
33°C, would be preferable to forming them at 31°C. In future studies,
it would be valuable to further characterize keratinocyte sheets by
looking at stemness markers and adhesion molecules to understand
how these may be influenced by thermal conditioning and how they
may enhance graft take rate and wound healing capacity.
Proteomics and hypothermic conditioning of keratinocyte sheets
Upon injury, a sequence of events starts in the epidermis to repair
the wound. This healing process is divided into three phases: inflam-
mation, proliferation and maturation. The biochemical mechanisms
underlying the wound healing process involve a number of cytokines
and growth factors [20]. The generation of a proteolytic environment
by inflammatory cells infiltrating the wound site as well as prolonged
upregulation of pro-inflammatory cytokines and chemokines inhib-
its, for example, the normal progression of wound healing. One
parameter that influences the productivity and duration of the bio-
factor production phase is cultivation temperature. The temperature-
dependent release of biofactors has been demonstrated using the
kinetics of individual factors [16,21]. With Chinese hamster ovary
cells, it has already been shown that the yield of recombinant pro-
teins and their quality can be improved at temperatures below 37°C
[22].
As observed with Chinese hamster ovary cells, the experiments
carried out in the present study showed that a standard temperature
of 37°C led to an early and rapid increase in biomarker secretion in
human keratinocytes as well. However, the secretion reached a peak
value for only a short time and quickly dropped within the analyzed
time window. By contrast, lower temperatures led to longer-lasting
secretion of biomarkers, with higher overall yields at 33°C and lower
yields at 31°C within the day 17 to day 25 observation window,
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which was the graft harvest window. Cultivation conditions of 33°C
for keratinocyte sheets resulted in optimal secretion of the angio-
genic factors VEGF and PDGF-bb within the observed time window
between day 17 and day 25 of culture. The increased level of released
angiogenic factors in the keratinocyte sheets could favor the forma-
tion of blood vessels after transplantation in vivo. Furthermore, der-
mal wound repair could be improved by the enhanced release of the
biomarker PDGF-bb, which is known to be a chemoattractant for
fibroblasts, monocytes and neutrophils [23]. Patients have already
been treated in the United States with PDGF-bb in completed ran-
domized clinical trials to improve wound healing [24].
The pro-inflammatory biomarkers IL-1 and IL-8 further support
the healing process in vivo [25]. In addition to the regulation of angio-
genesis [26], IL-1 is a highly active and pleiotropic pro-inflammatory
cytokine that stimulates keratinocyte growth and collagen synthesis
by fibroblasts and regulates hematopoiesis [27] by inducing the pro-
duction of different hematopoietic growth factors [28]. The release of
the biofactor IL-1b seems to be less temperature-sensitive during
keratinocyte sheet formation compared with the other biomarkers
tested. At all three temperature conditions, a comparable IL-1b
release over time was observed. During the inflammatory phase of
wound healing in vivo, TNF-a is also an important pro-inflammatory
mediator. As with pro-inflammatory cytokines, high levels of matrix
metalloproteinases have been found in inflammatory states such as
chronic wounds. In full-thickness human skin organ cultures, TNF-a
stimulates the release of active matrix metalloproteinase 2, which is
a type IV collagenase. This suggests a mechanism whereby TNF-a can
promote wound healing by indirectly stimulating inflammation and
increasing macrophage-produced growth factors [29].
The anti-inflammatory properties of the cytokines IL-10 and IL-4
demonstrate a negative feedback on keratinocytes when cultured at
lower temperatures. The ability of IL-10 to facilitate regenerative
healing is likely the result of pleiotropic effects through regulation of
the inflammatory response [30] as well as upregulation of endothelial
progenitor cells. Epidermal keratinocytes are a major source of IL-10
in skin. The production by keratinocytes in vitro was most notably
upregulated at 33°C compared with the conventional culture at 37°C.
The induction of IL-10 may contribute to the anti-inflammatory effect
leading to local and systemic immunosuppression after autologous
keratinocyte sheet transplantation.
The second investigated anti-inflammatory cytokine, IL-4, is able to
activate connective tissue cells and stimulate the accumulation of extra-
cellular matrix macromolecules such as collagen I and III. It regulates
extracellular matrix biogenesis via pre-translational mechanisms [31]
and might be involved in the regulatory role of epithelial differentiation
[32]. In experimental studies, the topical administration of IL-4 to
wounds has shown significant acceleration of the healing rate [33]. In
the current study, overall higher levels of secreted IFN-g could be
observed when sheets were cultivated at 33°C or 37°C. As a multi-func-
tional immunomodulatory cytokine, IL-4 initiates in keratinocytes the
host’s anti-viral defenses [34]. Furthermore, it is involved in angiogene-
sis and collagen deposition [35] and induces cytokines specific to mono-
nuclear cells. The IFN-g levels when sheets were cultivated at 31°C
seemed to only increase from day 23 onward—a typical delay in secre-
tion shown for many of the investigated biomarkers.
These results demonstrate that a cultivation temperature of 33°C
beneficially affected the production of immunomodulatory (IFN-g),
anti-inflammatory (IL-10, IL-4) and angiogenic (VEGF, PDGF-bb) biofac-
tors by keratinocytes during sheet formation (Table 1). Pro-inflamma-
tory factors (IL-1b, IL-8, TNF-a) were also more expressed at 33°C and
may play a role in wound healing through a positive feedback loop.
Overall, the in vivo effect of various biofactors secreted by the cultivated
sheets could not be accurately predicted in vitro. However, cultivating
sheets at 33°C showed the highest and most sustained levels of biofac-
tor release during the investigational graft harvest window 1725 days
after biopsy harvest. This would indicate that such active grafts may
exhibit a better take rate and stimulate the wound bed to accelerate
wound closure and healing once implanted in patients.
Although this study analyzed the keratinocyte sheet secretome in
the supernatant of sheet cultures, it may also be valuable in future
studies to determine protein levels in the graft itself and how these
may be influenced by thermal conditioning.
Storability
The regeneration of skin after skin graft transplantation depends
mainly on the viability of the graft. Viable grafts facilitate further
remodeling of the wound bed in vivo compared with non-viable
transplants [36]. In case of unforeseen events, the clinical process
may be delayed. It is questionable to what extent such short-term
storage would affect the viability of enzymatically harvested kerati-
nocyte sheets. It has been shown that cultured epidermal allografts
can be stored long-term through cryopreservation [37]. However, to
the authors’ knowledge, a shelf life between sheet harvest and trans-
plantation has not yet been described. The authors’ experiments
showed that the first 12 h of storage effected the greatest loss of via-
bility regardless of medium, temperature and presence of transfer
gauze. After 24 h of storage, it could be clearly seen that the effect
diminished. Compared with the sheets kept in storage without gauze,
those placed on Jelonet showed reduced viability. Nevertheless,
transfer gauze is necessary for handleability, and therefore investi-
gating various carriers may be valuable for maximizing graft stability
prior to implantation.
Although viability drops significantly after 12 h and may reach levels
below 50% of initial viability (0 h), the 50% threshold reference is not
indicative of clinical efficacy potential. Indeed, sheets may recover after
transplantation, and their efficacy in improving wound healing may not
require high viability at the time of transplantation. Although there may
be indications that the in vivo milieu may cause cell death in trans-
planted cell product [38], the required dosage of viable cells at trans-
plantation has not yet been linked to clinical efficacy. The findings in
this study simply show that the tested media had no significant influ-
ence on cell viability, but temperature appeared to have an effect, with
a lower storage temperature systematically improving viability in all
groups at all time points from 24 h onward.
The sheets maintained a similar viability of 34 § 20% (mean gray
value, 14 § 5) (Figure 8E) on the transport gauze Jelonet compared
with the control without transport gauze (viability, 32 § 11%, mean
gray value, 13 § 5) (Figure 8F) when kept at 4°C in CnT-2D medium.
When using Jelonet as a carrier gauze, it would therefore be prefera-
ble to store harvested sheets at 4°C in CnT-2D medium until trans-
plantation is possible. That being said, investigating alternate carrier
materials side by side may be beneficial in improving not only stor-
age viability but also keratinocyte sheet bioactivity and take rate.
Influence of temperature and pH buffer systems
To maintain the physiological pH value during in vitro cultivation,
suitable buffer systems have to be used. Thermal conditioning experi-
ments can have the limitation of coupling temperature changes to pH
changes simply as a result of CO2 solubility. The most common buffer
Table 1
Influence of thermal conditioning at 31°C, 33°C and 37°C on secretome
release of selected biofactors during keratinocyte sheet formation.
Effect Analyzed biofactors 31°C 33°C 37°C
Immunomodulatory IFN-g  ++ ++
Anti-inflammatory IL-10, IL-4  ++ +
Pro-inflammatory IL-1b, IL-8, TNF-a  ++ +
Angiogenic VEGF, PDGF-bb  ++ +
++ high, + medium,  low release.
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systems include physiological bicarbonate buffer (CO2/bicarbonate)
and non-volatile buffers such as 4-(2-hydroxyethyl)-1-piperazinee-
thanesulfonic acid (HEPES). Compared with buffering with bicarbon-
ate, HEPES buffer maintains the physiological pH value despite
temperature-mediated changes in CO2 solubility [39]. At cultivation
temperatures below 37°C, HEPES shows more effective buffering for
maintaining enzyme structures and functions since its dissociation
decreases with decreasing temperatures [40]. In this study, tempera-
ture and pH changes could be decoupled using the chosen CELLnTEC
medium, which contains both a bicarbonate and a HEPES buffering
system. Bicarbonate and HEPES would be resistant to temperature-
mediated changes in CO2 solubility and therefore the culture medium
pH in the temperature ranges used in this study.
Conclusions
The authors’ study may have important clinical implications, in that
the expanded window of grafting keratinocyte sheets (21 § 4 days after
biopsy harvest) will give surgeons the flexibility to decide when a graft-
ing procedure would be most successful based on the patient’s health
status. Primary keratinocytes display high proteomic consistency related
to constitutional factors such as sex, age and anatomic site [41]. How-
ever, hypothermic conditioning clearly affects the secretion of biofactors
during keratinocyte sheet culture. The optimized temperature condi-
tions of 37°C during the cell proliferation phase and 33°C within the dif-
ferentiation phase of human keratinocytes reflect the native
temperature gradient in normal healthy skin tissue [17]. By using 37°C
during the proliferation phase and 33°C during the sheet formation
phase of human keratinocytes, the production of cultivated skin grafts
can be accelerated and the quality of the grafts, as well as their bioactiv-
ity, can be improved, particularly at 33°C. Furthermore, using 4°C during
biopsy storage and sheet storage maximizes cell yield and viability.
With this protocol optimization, a flexible time window of day 18 to
day 25 was created in which a transplantation could take place. These
results could be of great benefit with regard to future clinical
approaches to the production of high-quality keratinocyte sheets and
could significantly improve the treatment of burn patients.
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